EdgeMarket › Instruments › FLNA

FLNA — FILANA THERAPEUTICS, INC.

Name: FLNA — FILANA THERAPEUTICS, INC. market data and filings
Creator: EdgeMarket

US Healthcare Pharma & biotech equity mkt cap 46.4M

0.96 +1.66% today

USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown

52w low 0.87 · high 4.64

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-05-10.

Performance

1 day+1.66%

1 week+5.22%

1 month+3.09%

3 months-25.50%

6 months-54.88%

Year to date-54.02%

1 year-55.09%

3 years-94.38%

5 years-99.22%

Technicals

RSI 1441.4

vs 50-day avg-10.43%

vs 200-day avg-47.37%

Volatility 1y90.2%

Max drawdown 1y-81.32%

Avg volume 30d324.0K

Daily bars held2,334

History from2017-05-10

Others in Healthcare

LLY +0.9%AKTX +1.6%JNJ +1.1%ONC +1.5%ABBV +1.2%MRK +2.4%UNH +1.4%NVS +1.7%

Insider transactions (Form 4)

date	insider	what	shares	price	value
2025-11-24	Anderson Robert Eugene Jr Director	Open-market purchase	8.6K	2.90	24.9K
2025-11-20	Barry Richard President & CEO	Open-market purchase	150.0K	2.76	414.0K
2025-11-19	Barry Richard President & CEO	Open-market purchase	73.4K	2.75	201.8K
2025-09-30	Cook Robert Christopher Chief Operating & Legal Office	Open-market purchase	13.7K	2.91	39.9K
2025-09-22	Barry Richard President & CEO	Open-market purchase	7.2K	2.28	16.4K
2025-09-19	Barry Richard President & CEO	Open-market purchase	46.9K	2.29	107.4K
2025-09-19	Barry Richard President & CEO	Open-market purchase	400	2.25	900
2025-09-18	Barry Richard President & CEO	Open-market purchase	185.2K	2.24	414.9K
2025-09-18	Barry Richard President & CEO	Open-market purchase	5.4K	2.13	11.5K
2024-11-29	Schoen Eric Chief Financial Officer	Open-market sale	59.8K	3.86	230.8K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

manager	value	shares
MARSHALL WACE, LLP	3.4M	2.0M
TWO SIGMA INVESTMENTS, LP	3.4M	2.0M
VANGUARD CAPITAL MANAGEMENT LLC	3.3M	1.9M
BlackRock, Inc.	2.4M	1.4M
GEODE CAPITAL MANAGEMENT, LLC	1.0M	596.2K
D. E. Shaw & Co., Inc.	945.1K	559.2K
GMT Capital Corp	760.7K	450.1K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	755.9K	447.3K
RENAISSANCE TECHNOLOGIES LLC	552.2K	326.8K
GROUP ONE TRADING LLC	511.4K	302.6K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d51.1% of tape

Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? · 2026-08-12

Ask the AI about FLNA

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open FLNA in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Create a free account Open the terminal first

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →